Myra F. Barginear

Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer

Arti Hurria, Enrique Soto‐Pérez‐de‐Celis, Jacob B. Allred et al. · Journal of the American Geriatrics Society · 2018 · 99 citations · Full text

Medicine, Geriatric Medicine, Oncology +14

Investigating the benefit of adding a vena cava filter to anticoagulation with fondaparinux sodium in patients with cancer and venous thromboembolism in a prospective randomized clinical trial

Myra F. Barginear, Richard J. Gralla, Thomas Bradley et al. · Supportive Care in Cancer · 2012 · 91 citations

Medicine, Oncology, Pharmacotherapy +17

Increasing Tamoxifen Dose in Breast Cancer Patients Based on CYP2D6 Genotypes and Endoxifen Levels: Effect on Active Metabolite Isomers and the Antiestrogenic Activity Score

Myra F. Barginear, Mariusz Jaremko, Inga Peter et al. · Clinical Pharmacology & Therapeutics · 2011 · 74 citations · Full text

Medicine, Oncology, Pharmacology +17

Trastuzumab-DM1: A Clinical Update of the Novel Antibody-Drug Conjugate for HER2-Overexpressing Breast Cancer

Myra F. Barginear, Veena S. John, Daniel R. Budman · Molecular Medicine · 2012 · 59 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Need for Inferior Vena Cava Filters in Cancer Patients: A Surrogate Marker for Poor Outcome

Myra F. Barginear, Martin Lesser, Meredith Akerman et al. · Clinical and Applied Thrombosis/Hemostasis · 2008 · 36 citations

Medicine, Oncology, Cancer Control +13